Hepatology
- DISEASE INDICATIONS: Alagille syndrome
- MANUFACTURER: Mirum Pharmaceuticals
- USAGE: Oral
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
Livmarli (maralixibat) is a prescription medicine used to treat cholestatic pruritus (itch) in patients with Alagille syndrome 3 months of age and older.
Read more